/ Active, not recruitingPhase 1 单中心、随机、双盲、单剂量、平行比较地舒单抗注射液(HL05-2)与普罗力®在健康男性参与者中药代动力学相似性和安全性的Ⅰ期临床研究
[Translation] A single-center, randomized, double-blind, single-dose, parallel phase I clinical study comparing the pharmacokinetic similarity and safety of denosumab injection (HL05-2) and Prolix® in healthy male participants
比较地舒单抗注射液(HL05-2)与普罗力®在健康男性参与者中药代动力学相似性和安全性。
[Translation] To compare the pharmacokinetic similarity and safety of denosumab injection (HL05-2) and Prolix® in healthy male participants.
100 Clinical Results associated with Hualan Genetic Engineering (Henan) Co.,Ltd
0 Patents (Medical) associated with Hualan Genetic Engineering (Henan) Co.,Ltd
100 Deals associated with Hualan Genetic Engineering (Henan) Co.,Ltd
100 Translational Medicine associated with Hualan Genetic Engineering (Henan) Co.,Ltd